arrow
E

Elena Fiorio

university of verona hospital trust
H指数:17
被引数:827

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Real-world feasibility and effectiveness of a personalized exercise program during cancer treatment: results from the CHOiCE prospective study

癌症治疗期间个性化运动方案的现实可行性与有效性:CHOiCE前瞻性研究的结果

2026-04-210
OA
DonnaRosa Project: Exploring Informal Communication Practices Among Breast Cancer Specialists

DonnaRosa 项目:探索乳腺癌专家之间的非正式沟通实践

2025-12-140
OAAI
Lifestyle and environmental factors in women carrying BRCA pathogenic variants with and without cancer

携带BRCA致病性变异的癌症患者与非癌症患者的女性生活方式及环境因素

2025-12-010
OAAI
Prediction of response to neoadjuvant chemotherapy by MammaTyper® across breast cancer subtypes: A retrospective cross-sectional study

MammaTyper对新辅助化疗反应的预测®跨乳腺癌亚型: 一项回顾性横断面研究

BREAST
IF7.9
2024-08-011
OAAI
Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study

卡培他滨辅助治疗新辅助治疗后有残留病灶的三阴性乳腺癌患者: 来自CaRe的真实世界证据,一项多中心观察性研究

2023-05-165
OAAI
Development of a nomogram for predicting pathological complete response in luminal breast cancer patients following neoadjuvant chemotherapy

新辅助化疗后预测腔型乳腺癌患者病理完全缓解的列线图的开发

2023-03-141
OAAI
Predictive and prognostic effect of computed tomography-derived body composition analysis during neoadjuvant chemotherapy for operable and locally advanced breast cancer

可手术和局部晚期乳腺癌新辅助化疗期间计算机断层扫描衍生的身体成分分析的预测和预后作用

2023-01-014
PRE
Evidence-based tailored nutrition educational intervention improves adherence to dietary guidelines, anthropometric measures and serum metabolic biomarkers in early-stage breast cancer patients: A prospective interventional study

基于证据的量身定制的营养教育干预可改善早期乳腺癌患者对饮食指南,人体测量指标和血清代谢生物标志物的依从性: 一项前瞻性干预研究

BREAST
IF7.9
2021-12-0111
OAAI
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting

Paner研究: 一项来自真实世界环境的HER2-positive晚期乳腺癌患者的多中心观察性研究的20年治疗结果分析

2021-11-296
OAAI
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic
2020-08-0119
OAAI
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model
BREAST
IF7.9
2020-04-014
OAAI
Phase II, open label, randomized, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with operable, locally advanced, or inflammatory HER2-positive breast cancer. ImmunHER trial on behalf of the Gruppo Oncologico Italiano di Ricerca Clinica (GOIRC)
2020-02-150
PRE
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting

不同的HR表达模式显着影响转移性HER2乳腺癌的临床行为以及在现实世界环境中从新型anti-HER2药物中获益的程度

2019-08-075
OAAI